Header

UZH-Logo

Maintenance Infos

Early and late mortality in patients undergoing transcatheter aortic valve implantation: Comparison of the Novel EuroScore II with established risk scores


Stähli, Barbara E; Tasnady, Hanna; Lüscher, Thomas F; Gebhard, Cathérine; Mikulicic, Fran; Erhart, Ladina; Bühler, Ines; Landmesser, Ulf; Altwegg, Lukas; Wischnewsky, Manfred B; Grünenfelder, Jürg; Falk, Volkmar; Corti, Roberto; Maier, Willibald (2013). Early and late mortality in patients undergoing transcatheter aortic valve implantation: Comparison of the Novel EuroScore II with established risk scores. Cardiology, 126(1):15-23.

Abstract

Objectives: In the evaluation of patients considered for transcatheter aortic valve implantation (TAVI), the EuroScore II might be superior to established risk scores. Methods: We assessed the performance of the EuroScore II in predicting mortality in a cohort of 350 TAVI patients. Results: The EuroScore II and the logistic EuroScore were higher in nonsurvivors compared to survivors at 30 days (12.6 ± 1.8 vs. 7.5 ± 0.3%, p < 0.001 for EuroScore II, and 27.7 ± 2.8 vs. 22.1 ± 0.8%, p = 0.04 for logistic EuroScore), while the STS-PROM score did not differ (7.3 ± 0.8 vs. 6.4 ± 0.3%, p = 0.09). The area under the curve (AUC) was 0.70 for the EuroScore II, 0.61 for the logistic EuroScore and 0.59 for the STS-PROM score for predicting 30-day mortality. Based on the estimated 30-day mortality risk, 3 risk groups were identified, a low-risk (EuroScore II ≤4%, 30-day mortality 1.2%), an intermediate-risk (EuroScore II between 4% and 9%, 30-day mortality 8.6%) and a high-risk group (EuroScore II >9%, 30-day mortality, 17.1%; p = 0.03). Regarding cumulative mortality, the AUC was 0.67 for the EuroScore II, 0.62 for the logistic EuroScore and 0.55 for the STS-PROM score for predicting mortality at total follow-up. Conclusions: In this patient cohort, the EuroScore II performed best in predicting short- and long-term mortality.

Abstract

Objectives: In the evaluation of patients considered for transcatheter aortic valve implantation (TAVI), the EuroScore II might be superior to established risk scores. Methods: We assessed the performance of the EuroScore II in predicting mortality in a cohort of 350 TAVI patients. Results: The EuroScore II and the logistic EuroScore were higher in nonsurvivors compared to survivors at 30 days (12.6 ± 1.8 vs. 7.5 ± 0.3%, p < 0.001 for EuroScore II, and 27.7 ± 2.8 vs. 22.1 ± 0.8%, p = 0.04 for logistic EuroScore), while the STS-PROM score did not differ (7.3 ± 0.8 vs. 6.4 ± 0.3%, p = 0.09). The area under the curve (AUC) was 0.70 for the EuroScore II, 0.61 for the logistic EuroScore and 0.59 for the STS-PROM score for predicting 30-day mortality. Based on the estimated 30-day mortality risk, 3 risk groups were identified, a low-risk (EuroScore II ≤4%, 30-day mortality 1.2%), an intermediate-risk (EuroScore II between 4% and 9%, 30-day mortality 8.6%) and a high-risk group (EuroScore II >9%, 30-day mortality, 17.1%; p = 0.03). Regarding cumulative mortality, the AUC was 0.67 for the EuroScore II, 0.62 for the logistic EuroScore and 0.55 for the STS-PROM score for predicting mortality at total follow-up. Conclusions: In this patient cohort, the EuroScore II performed best in predicting short- and long-term mortality.

Statistics

Citations

25 citations in Web of Science®
27 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

92 downloads since deposited on 04 Nov 2013
31 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiovascular Surgery
04 Faculty of Medicine > Institute of Physiology
07 Faculty of Science > Institute of Physiology

04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2013
Deposited On:04 Nov 2013 12:42
Last Modified:07 Dec 2017 23:00
Publisher:Karger
ISSN:0008-6312
Additional Information:© 2013 S. Karger AG
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1159/000351438
PubMed ID:23912448

Download

Download PDF  'Early and late mortality in patients undergoing transcatheter aortic valve implantation: Comparison of the Novel EuroScore II with established risk scores'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 597kB
View at publisher
Download PDF  'Early and late mortality in patients undergoing transcatheter aortic valve implantation: Comparison of the Novel EuroScore II with established risk scores'.
Preview
Content: Published Version
Filetype: PDF
Size: 774kB